Skip to Main Content

Sylvester at
2024 American Society of
Clinical Oncology
Annual Meeting

May 31 – June 4, 2024
Chicago, IL & Online

#ASCO24 #OnlySylvester

BOOTH: #10048

At Sylvester Comprehensive Cancer Center, part of the University of Miami Health System and the Miller School of Medicine, we are the only NCI-designated and academic-based cancer center in South Florida, enabling more impactful science. We are South Florida’s leader in cancer research and care, specializing in treating the toughest cancers with comprehensive support from diagnosis to survivorship.

Our Featured Sessions

Carl Ola Landgren, M.D.

Oral Abstract Session

Multiple Myeloma

Discussant: Carl Ola Landgren, M.D.

Session: The More the Better? Quadruplets in Newly Diagnosed Multiple Myeloma

June 3, 3:36 PM – 3:48 PM
Hall D1 - Live Stream

Jonathan Trent, M.D.

Oral Abstract Session

Hematologic Malignancies

Co-author: Jonathan Trent, M.D.

Session: StrateGIST 1: A first-in-human (FIH), phase 1 study of IDRX-42 in patients with metastatic gastrointestinal stromal tumors resistant to prior treatment with tyrosine kinase inhibitors (TKIs).

June 3, 3:12 PM – 3:24 PM
S100bc | Live Stream

Coral Olazagasti, M.D.

Rapid Oral Abstract Session

Medical Education and Professional Development

Presenter: Coral Olazagasti, M.D.

Session: Assessing gender disparities in oncology: Less talk, more action.

June 3, 10:57 AM – 11:03 AM
E450a | On Demand

Highlights of our Presentations

Oral Presentations:

DATE/TIME: May 31, 3:45 PM – 3:57 PM
TITLE: Post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis following mismatched unrelated donor peripheral blood stem cell (PBSC) transplantation
LOCATION: S100bc | Live Stream
ABSTRACT #: 6503
SENIOR AUTHOR: Antonio Jimenez Jimenez

DATE/TIME: May 31, 5:09 PM – 5:21 PM
TITLE: Safety and efficacy of first-in-class CXCR1/2 inhibitor SX-682 in combination with pembrolizumab (pem) in patients (pts) with metastatic melanoma (mMEL) with disease progression on anti–PD-1 therapy
LOCATION: Hall D1 | Live Stream
ABSTRACT #: 9508
CO-AUTHOR: Leonel Hernandez-Aya

Learn More about Our Research from our Experts



physicians, scientists, and staff dedicated to cancer research and care
Research Programs:
  1. Tumor Biology
  2. Cancer Epigenetics
  3. Translational and Clinical Oncology
  4. Cancer Control
in peer-reviewed funding from NCI, NIH and other sources | $25M in non-peer-reviewed funding
participants in 456 clinical research studies (interventional and non-interventional)

Additional Information

Media Contact:

Gary Polakovic
Phone: (305) 213-4642

Sylvester Social Media

Follow our ASCO coverage on X and LinkedIn

Connect: alt="Twitter Logo"> Linkedin Icon